Business ❯Mergers and Acquisitions ❯Pharmaceutical Industry ❯Cancer Treatment

Next-Gen Cancer Makers

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline